Researchers demonstrate in mice that glands in the uterus must link and communicate directly with the embryo so it will implant and begin pregnancy. The study was published in the Nature Communications
The study's senior investigator, Sudhansu K said, "We show that glands nourish the embryos within the crypt by forging a direct connection between the two entities." "The gland secretions produce molecules essential to embryo development. Without Vangl2, the glands do not extend and connect to the embryo, and the embryo does not properly implant."
The researchers are looking for answers to pregnancy problems to help address high rates of preterm birth and infant mortality, which remain persistent health challenges in modern society. This study is just one puzzle piece in an expanding body of research trying to unravel the genetic, molecular and lifestyle causes.
3D View of Pregancy
In their study, researchers produced unprecedented visual and molecular detail about the early stages of a normal mouse pregnancy. They then compared normal mouse pregnancy to malformations that occur in the uterus when the gene Vangl2 is deleted from epithelial cells in the lining of uterine cells and glands.
In the normal mouse pregnancy, researchers show that glands providing vital molecular support from the mother to developing embryo extend from the uterine lining and connect directly to the embryo.
This connection occurs inside implantation chambers in the uterus called crypts. The study reveals that glands remain connected to embryos through pregnancy's early stages. Dey said this is to ensure a competent embryo properly implants in crypts–a critical step to beginning a healthy pregnancy.
After disrupting embryo implantation and pregnancy in the mice, the scientists wanted to uncover the molecular mechanism makes glands extend to the embryo and promote implantation. They learned that a growth factor protein called HB-EGF (heparin-binding EGF like growth factor) coordinates with Vangl2 to initiate this process.
HB-EGF is normally expressed in the embryo and crypt. To simulate what occurs in pregnancy, the researchers transferred embryo-sized beads soaked with HB-EGF into the mice uteri. Even in the absence of implanting embryos, the HB-EGF-carrying beads displayed implantation-like responses and showed gland-crypt interaction.
Earlier studies by Dey et al found that HB-EGF is one of the earliest molecular markers for embryo-uterine interaction in implantation. He said the current study adds important new insight to the field of reproductive science by showing what takes place when HB-EGF is expressed by a competent early embryo.
Researchers then tested what happened when they administered HB-EGF to mice with deleted Vangl2. Genetic deletion caused mice uterine glands to form improperly and wither the implantation chamber.
Still unclear at this point is how the current study's findings apply to human pregnancy, according to Dey and his colleagues. The study opens doors to future research possibilities in other animal models that more closely approximate human pregnancy.
Researcher said further research is warranted into the potential of HB-EGF as a therapy for problems in pregnancy. But he emphasized the current study's findings only allow conclusions about mouse pregnancy.